Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0545120170270111932
Journal of Microbiology and Biotechnology
2017 Volume.27 No. 11 p.1932 ~ p.1941
In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in Mycobacterium tuberculosis
Kim Su-Kyung

Seo Hoon-Hee
Mahmud Hafij Al
Islam Imtiazul
Kim Yong-Sik
Lyu Ji-Won
Nam Kung-Woo
Lee Byung-Eui
Lee Kee-In
Song Ho-Yeon
Abstract
DFC-2, a methyl 5-[2-(dimethylamino)ethoxy]-7,12-dioxo-7,12-dihydrodinaphtho[1,2-b:2¡¯,3¡¯- d]furan-6-carboxylate, is reported to have antitubercular effects against Mycobacterium tuberculosis. At concentrations ranging from 0.19 to 0.39 ¥ìg/ml, DFC-2 inhibited both drugsusceptible and ?resistant strains of M. tuberculosis. Microarray analyses were employed to gain insights into the molecular mechanisms of DFC-2¡¯s action in M. tuberculosis. The most affected functional gene category was ¡°lipid biosynthesis,¡± which is involved in mycolic acid synthesis. The decrease in transcription of genes related to mycolic acid synthesis was confirmed by RT-PCR. Furthermore, we found that DFC-2 triggered a reduction in mycolic acid levels, showing a similar pattern to that of mycolic acid synthesis inhibitor isoniazid. These results may explain how this compound kills mycobacteria efficiently by inhibiting mycolic acid synthesis.
KEYWORD
DFC-2, mycolic acid, M. tuberculosis
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI)